Abstract
Signals from the tumor microenvironment trigger cancer cells to adopt an invasive phenotype through epithelial–mesenchymal transition (EMT). Relatively little is known regarding key signal transduction pathways that serve as cytosolic bridges between cell surface receptors and nuclear transcription factors to induce EMT. A better understanding of these early EMT events may identify potential targets for the control of metastasis. One rapid intracellular signaling pathway that has not yet been explored during EMT induction is calcium. Here we show that stimuli used to induce EMT produce a transient increase in cytosolic calcium levels in human breast cancer cells. Attenuation of the calcium signal by intracellular calcium chelation significantly reduced epidermal growth factor (EGF)- and hypoxia-induced EMT. Intracellular calcium chelation also inhibited EGF-induced activation of signal transducer and activator of transcription 3 (STAT3), while preserving other signal transduction pathways such as Akt and extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation. To identify calcium-permeable channels that may regulate EMT induction in breast cancer cells, we performed a targeted siRNA-based screen. We found that transient receptor potential-melastatin-like 7 (TRPM7) channel expression regulated EGF-induced STAT3 phosphorylation and expression of the EMT marker vimentin. Although intracellular calcium chelation almost completely blocked the induction of many EMT markers, including vimentin, Twist and N-cadherin, the effect of TRPM7 silencing was specific for vimentin protein expression and STAT3 phosphorylation. These results indicate that TRPM7 is a partial regulator of EMT in breast cancer cells, and that other calcium-permeable ion channels are also involved in calcium-dependent EMT induction. In summary, this work establishes an important role for the intracellular calcium signal in the induction of EMT in human breast cancer cells. Manipulation of calcium-signaling pathways controlling EMT induction in cancer cells may therefore be an important therapeutic strategy for preventing metastases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kalluri R, Weinberg RA . The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420–1428.
Zeisberg M, Neilson EG . Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119: 1429–1437.
Nieto MA . The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 2011; 27: 347–376.
Polyak K, Weinberg RA . Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9: 265–273.
Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010; 12: R68.
Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J . Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008; 68: 989–997.
Proia TA, Keller PJ, Gupta PB, Klebba I, Jones AD, Sedic M et al. Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. Cell Stem Cell 2011; 8: 149–163.
DiMeo TA, Anderson K, Phadke P, Fan C, Perou CM, Naber S et al. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res 2009; 69: 5364–5373.
Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, Zhou AY et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704–715.
Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 2009; 106: 13820–13825.
Thiery JP, Acloque H, Huang RYJ, Angela Nieto M . Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871–890.
Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007; 213: 374–383.
Lo H-W, Hsu S-C, Xia W, Cao X, Shih J-Y, Wei Y et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 2007; 67: 9066–9076.
Berg T . Inhibition of transcription factors with small organic molecules. Curr Opin Chem Biol 2008; 12: 464–471.
Berridge MJ, Bootman MD, Roderick HL . Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003; 4: 517–529.
Ronnov-Jessen L, Bissell MJ . Breast cancer by proxy: can the microenvironment be both the cause and consequence? Trends Mol Med 2009; 15: 5–13.
Monteith GR, Davis FM, Roberts-Thompson SJ . Calcium channels and pumps in cancer: changes and consequences. J Biol Chem 2012; 287: 31666–31673.
Yang SL, Cao Q, Zhou KC, Feng YJ, Wang YZ . Transient receptor potential channel C3 contributes to the progression of human ovarian cancer. Oncogene 2009; 28: 1320–1328.
Prevarskaya N, Skryma R, Shuba Y . Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 2011; 11: 609–618.
Monet M, Lehen'kyi Vy, Gackiere F, Firlej V, Vandenberghe M, Roudbaraki M et al. Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance. Cancer Res 2010; 70: 1225–1235.
Yang S, Zhang JJ, Huang X-Y . Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 2009; 15: 124–134.
Davis FM, Peters AA, Grice DM, Cabot PJ, Parat MO, Roberts-Thomson SJ et al. Non-stimulated, agonist-stimulated and store-operated Ca2+ influx in MDA-MB-468 breast cancer cells and the effect of EGF-induced EMT on calcium entry. PLoS ONE 2012; 7: e36923.
Hu JJ, Qin KH, Zhang Y, Gong JB, Li N, Lv D et al. Downregulation of transcription factor Oct4 induces an epithelial-to-mesenchymal transition via enhancement of Ca(2+) influx in breast cancer cells. Biochem Biophys Res Commun 2011; 411: 786–791.
Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, Foidart JM et al. Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 1999; 112: 4615–4625.
Bonnomet A, Syne L, Brysse A, Feyereisen E, Thompson EW, Noel A et al. A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer. Oncogene 2011; 31: 3741–3753.
Wyckoff J, Wang WG, Lin EY, Wang YR, Pixley F, Stanley ER et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004; 64: 7022–7029.
Berridge MJ, Lipp P, Bootman MD . The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000; 1: 11–21.
Ji QS, Carpenter G . Role of basal calcium in the EGF activation of MAP kinases. Oncogene 2000; 19: 1853–1856.
Cook SJ, Beltman J, Cadwallader KA, McMahon M, McCormick F . Regulation of mitogen-activated protein kinase phosphatase-1 expression by extracellular signal-related kinase-dependent and Ca2+-dependent signal pathways in Rat-1 cells. J Biol Chem 1997; 272: 13309–13319.
Colomiere M, Ward AC, Riley C, Trenerry MK, Cameron-Smith D, Findlay J et al. Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas. Br J Cancer 2009; 100: 134–144.
Wei C, Wang X, Chen M, Ouyang K, Song L-S, Cheng H . Calcium flickers steer cell migration. Nature 2009; 457: 901–905.
Cheng X, Jin J, Hu L, Shen D, Dong X-P, Samie MA et al. TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation. Cell 2010; 141: 331–343.
Gao H, Chen X, Du X, Guan B, Liu Y, Zhang H . EGF enhances the migration of cancer cells by up-regulation of TRPM7. Cell Calcium 2011; 50: 559–568.
Middelbeek J, Kuipers AJ, Henneman L, Visser D, Eidhof I, van Horssen R et al. TRPM7 is required for breast tumor cell metastasis. Cancer Res 2012; 72: 4250–4261.
Chubanov V, Mederos y Schnitzler M, Meissner M, Schafer S, Abstiens K, Hofmann T et al. Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7. Br J Pharmacol 2012; 166: 1357–1376.
Langeslag M, Clark K, Moolenaar WH, van Leeuwen FN, Jalink K . Activation of TRPM7 channels by phospholipase C-coupled receptor agonists. J Biol Chem 2007; 282: 232–239.
Ramsey IS, Delling M, Clapham DE . An introduction to TRP channels. Annu Rev Physiol 2006; 68: 619–647.
Shabir S, Southgate J . Calcium signalling in wound-responsive normal human urothelial cell monolayers. Cell Calcium 2008; 44: 453–464.
Chang HY, Nuyten DSA, Sneddon JB, Hastie T, Tibshirani R, Sorlie T et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 2005; 102: 3738–3743.
Grande M, Franzen A, Karlsson JO, Ericson LE, Heldin NE, Nilsson M . Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J Cell Sci 2002; 115: 4227–4236.
Su LT, Liu W, Chen HC, Gonzalez-Pagan O, Habas R, Runnels LW . TRPM7 regulates polarized cell movements. Biochem J 2011; 434: 513–521.
Takahashi T, Fukuda K, Pan J, Kodama H, Sano M, Makino S et al. Characterization of insulin-like growth factor-1-induced activation of the JAK/STAT pathway in rat cardiomyocytes. Circ Res 1999; 85: 884–891.
Vultur A, Cao J, Arulanandam R, Turkson J, Jove R, Greer P et al. Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells. Oncogene 2004; 23: 2600–2616.
Mellstrom B, Savignac M, Gomez-Villafuertes R, Naranjo JR . Ca2+-operated transcriptional networks: molecular mechanisms and in vivo models. Physiol Rev 2008; 88: 421–449.
Mancini M, Toker A . NFAT proteins: emerging roles in cancer progression. Nat Rev Cancer 2009; 9: 810–820.
Davis FM, Kenny PA, Soo ETL, van Denderen BJW, Thompson EW, Cabot PJ et al. Remodeling of purinergic receptor-mediated Ca(2+) signaling as a consequence of EGF-induced epithelial-mesenchymal transition in breast cancer cells. PLoS ONE 2011; 6: e23464.
Clark K, Langeslag M, van Leeuwen B, Ran L, Ryazanov AG, Figdor CG et al. TRPM7, a novel regulator of actomyosin contractility and cell adhesion. EMBO J 2006; 25: 290–301.
Lundgren K, Nordenskjold B, Landberg G . Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer. Br J Cancer 2009; 101: 1769–1781.
Lester RD, Jo M, Montel V, Takimoto S, Gonias SL . uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J Cell Biol 2007; 178: 425–436.
Liang C-C, Park AY, Guan J-L . In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007; 2: 329–333.
Elgoyhen AB, Vetter DE, Katz E, Rothlin CV, Heinemann SF, Boulter J . alpha 10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc Natl Acad Sci USA 2001; 98: 3501–3506.
Grice DM, Vetter I, Faddy HM, Kenny PA, Roberts-Thomson SJ, Monteith GR . Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of insulin-like growth factor receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231. J Biol Chem 2010; 285: 37458–37466.
Suchanek KM, May FJ, Robinson JA, Lee WJ, Holman NA, Monteith GR et al. Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231. Mol Carcinog 2002; 34: 165–171.
Acknowledgements
The research was partially supported by the National Health and Medical Research Council (NHMRC; project grants 569645 and 1022263) and the Intramural Research Program of the US National Institutes of Health, National Institute of Environmental Health Sciences (NIEHS). FD was funded by an NHMRC Biomedical Postgraduate Scholarship (511262), RF was funded by a UQ Postdoctoral Fellowship and EWT was funded in part by the National Breast Cancer Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Davis, F., Azimi, I., Faville, R. et al. Induction of epithelial–mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent. Oncogene 33, 2307–2316 (2014). https://doi.org/10.1038/onc.2013.187
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2013.187
Keywords
This article is cited by
-
Stanniocalcin 2 drives malignant transformation of human glioblastoma cells by targeting SNAI2 and Matrix Metalloproteinases
Cell Death Discovery (2022)
-
The effects of hypoxia on female reproductive system diseases
Genome Instability & Disease (2022)
-
Expression and associated epigenetic mechanisms of the Ca2+-signaling genes in breast cancer subtypes and epithelial-to-mesenchymal transition
Journal of Cell Communication and Signaling (2022)
-
Endolysosomal ion channel MCOLN2 (Mucolipin-2) promotes prostate cancer progression via IL-1β/NF-κB pathway
British Journal of Cancer (2021)
-
The role of calcium oscillations in the phenotype selection in endothelial cells
Scientific Reports (2021)